º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Enterprise

Y-Combinator-backed Supplant seeks rescue buyer after entering administration

Supplant, which uses sugars made from fibre in confectionery items, has been put up for sale after being plunged into administration

Supplant’s technology helped make sweet treats healthier.(Image: Getty Images)

An agritech company supported by investors including Y-Combinator has been placed on the market following its collapse into administration, City AM can reveal.

Cambridge-headquartered Supplant, which had secured over £25m in investment since its inception, is currently seeking a rescue purchaser and will consider bids exceeding just £2.5m, according to an insolvency marketplace listing viewed by City AM.

The business, which also maintained operations in the US, employed approximately three dozen personnel at its height, generating revenues of roughly $1m, as reported by .

Trade creditor liabilities totalled $2m whilst the company also carried an outstanding $3.6m loan facility with California-based venture lender Western Technology Investment.

Supplant was established to produce sugars from fibre which could subsequently be utilised in confectionery products such as biscuits, cakes and chocolates.

In contrast to conventional cane sugar, fibre-derived sugars function physiologically differently within the body, enabling sweet foods to exert a reduced impact on blood-sugar levels, rendering them healthier for the digestive system.

The company had also developed its own flour for pasta applications, which claimed to contain fewer calories and up to three times the fibre content.

The products were manufactured from what Supplant termed "the forgotten half of the harvest" – the fibre-rich, structural components of crops such as corn cobs, oat hulls and wheat stalks which are frequently discarded. The firm was established in 2017 by Cambridge scholar Dr Tom Simmons, a postdoctoral researcher at the department of biochemistry.